Govt extends Schedule M implementation deadline till year-end for small, medium pharma firms

The implementation of revised Schedule M for good manufacturing practices has been conditionally extended to December 31, 2025, for small and medium pharmaceutical firms with turnover of Rs 250 crore or less. These firms must submit an upgrade plan by February 11, 2025, to qualify for the deadline extension. The updated regulations aim to enhance product quality and global competitiveness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zZvXmIu
via IFTTT